Executive record

Kyle Carver, M.B.A., C.P.A.

Director at PLUS THERAPEUTICS, INC.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:kyle-guse-esq-mba-cpaVersion: public-0As of: 2026-09-29

Not yet claimed11 published Claims4 sources
  • Director

Key Claims

Biography

Served as Chief Accounting Officer at Kadmon Holdings, Inc. (a Sanofi Company) overseeing financial and accounting operations, and previously held a senior role at KPMG serving life sciences clients.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Board service

Boards

Claims

Executive career

  1. 2026 to end not publishedExecutive title: Chief Financial Officer · Organization not publishedEVMN DEF 14A executive officers
  2. Dates not publishedExecutive title: Chief Legal Officer · Organization not publishedPSTV DEF 14A director slate

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

4 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. EVMN DEF 14A executive officers

    sec filing · Source published: Apr 21, 2026 · Retrieved: May 16, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Executive company: Executive at Evommune, Inc. · Claim reviewed: May 16, 2026
    • Executive title: Executive title: Chief Financial Officer · Claim reviewed: May 16, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 16, 2026

  2. PSTV DEF 14A director slate

    sec filing · Source published: Mar 31, 2026 · Retrieved: May 16, 2026

    Supports 7 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Board role: Board role: Director · Claim reviewed: May 16, 2026
    • Committee assignments: Committee assignments: Audit, Compensation · Claim reviewed: May 16, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Executive company: Executive at DDC Enterprise Ltd. · Claim reviewed: May 16, 2026
    • Executive title: Executive title: Chief Legal Officer · Claim reviewed: May 16, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 16, 2026

  3. Open source

    sec proxy · Source published: Mar 31, 2026 · Retrieved: Apr 25, 2026

    Supports 1 claim
    • Professional Role: Director at PLUS THERAPEUTICS, INC. · Claim reviewed: May 16, 2026

  4. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of PLUS THERAPEUTICS, INC. · Claim reviewed: May 16, 2026